在巴西患有2型先天性泛性脂质变质症的患者中使用米特利普丁的长期临床经验
相关实验视频
Updated: Sep 10, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
348
Isabella Sued Leão1, Joana Rodrigues Dantas1, Sarah Galvão2
1Medical Clinic Department, Nutrology and Diabetes Unit, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 21941-913, Brazil.
JCEM case reports
|August 27, 2025
概括
在患有2型先天性泛性脂质变质症的患者中,米特利普丁有效地控制了8年的代谢功能. 在这些患者中,持续的甲素治疗对于持续的代谢控制至关重要.
科学领域:
- 内分泌学
- 遗传学
- 代谢疾病
背景情况:
- 具有严重的胰岛素耐药性的2型先天性泛性脂质变异 (BSCL2基因突变).
- 梅特利普丁是一种治疗脂质疏松症的瘦素替代疗法.
- 对于与BSCL2相关的脂质变症的长期数据有限.
更多相关视频
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
257
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
257
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K

